Articles tagged with Multiple Sclerosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers used gene therapy to stop the immune response that causes multiple sclerosis in mouse models, producing near-complete remission. The treatment combined a brain-protein gene with an existing medication, showing significant potential for treating multiple sclerosis and other autoimmune disorders.
A recent study demonstrated that the prospect of monetary reward stimulates the fronto-striatal network, resulting in reduced cognitive fatigue in individuals with MS and healthy controls. This nonpharmacological approach shows promise for treating cognitive fatigue in multiple sclerosis.
A study published in the Annals of Neurology found a link between adolescent concussions and an increased risk of multiple sclerosis. The study, which analyzed over 7,000 patients, found that repeated head trauma was associated with a significantly higher likelihood of developing the condition.
Researchers identified two cytokines and genetic markers associated with progressive MS, which may enable the development of a treatment to prevent disease progression. A simple genetic test could identify patients at risk, and a medication is already in development.
A new four-year project will collect data on three methods of delivering a self-management course to reduce MS-related fatigue and improve quality of life. The study aims to test online and teleconference-based adaptations of the course, which has shown effective results in reducing fatigue when delivered in-person.
Researchers identified macrophage migration inhibitory factor (MIF) and its related protein D-dopachrome tautomerase as closely related cytokines associated with progressive MS. A genetic test could identify patients at risk of developing the disease, accelerating drug development for precision medicine.
A new study suggests that correcting vitamin D deficiency in young and middle-age women can reduce their future risk of multiple sclerosis. Deficient levels of vitamin D were found to be associated with a higher risk of developing MS, with a 39% decrease in risk for each 50 nmol/L increase.
A new clinical trial aims to explore the effectiveness of modafinil, cognitive behavioral therapy, and a combination of both in reducing MS fatigue. The study will provide valuable insights to help patients and clinicians make informed decisions about treatment options.
The PCORI Board approved $38 million to fund five studies comparing different treatment approaches for people with multiple sclerosis. The projects will focus on topics such as fatigue management and exercise programs to improve care delivery and patient outcomes.
Researchers found significant differences in bacterial genera between MS patients and healthy controls, with Acinetobacter and Akkermansia being more abundant in patients. Exposure to extracts from these bacteria increased proinflammatory T cell differentiation and inhibited regulatory T cell differentiation.
Researchers identified specific gut microbes associated with multiple sclerosis, suggesting they play a role in regulating immune responses and potentially contributing to disease progression. The study found that certain bacteria can trigger pro-inflammatory or anti-inflammatory responses in the immune system.
Kessler researchers found that traumatic brain injury (TBI) causes cognitive fatigue by activating the caudate nucleus, a key brain region. This discovery has important implications for developing effective treatments.
Researchers found a strong biological link between Epstein-Barr virus and multiple sclerosis (MS) across three racial groups. The study found that blacks, Hispanics, and whites who had mononucleosis were more than two to nearly four times more likely to develop MS than those who did not.
A study by Queen Mary University of London found that MS drug cladribine improves patients' mobility and self-care, in addition to reducing relapses. The benefits were significant enough for the European Medicines Agency to adopt a positive opinion on licensing the oral preparation.
A five-year federal research grant will fund studies on the gut microbiome's role in MS, led by Yanjiao Zhou. The research aims to investigate how intermittent fasting alters the gut microbiome and may reduce MS symptoms.
Dr. John DeLuca has been awarded the Fred Foley Award for his outstanding contributions to advancing research in cognitive impairments in Multiple Sclerosis (MS). His work aims to improve quality of life by developing effective non-invasive treatments to minimize the effects of MS on cognitive performance.
University at Buffalo researchers have developed a method to compare human and rodent cells, providing insight into gene expression patterns conserved across species. This approach identified a new gene involved in myelin repair that may become a therapeutic target for MS patients.
Researchers at Mayo Clinic and University of Iowa found a human gut microbe, Prevotella histicola, that effectively suppresses immune disease in a mouse model of MS. The study suggests that this microbe may play a role in treating MS, an autoimmune disease caused by the immune system's attack on the myelin sheath.
A recent study from the University of Illinois sheds light on what may be happening in the brains of MS patients during upper respiratory infections. Researchers found an increase in glial activation and elevated levels of chemokine CXCL5, which could lead to a drug intervention to inhibit relapses.
A study published in Multiple Sclerosis Journal shows that resistance training can protect the brain and delay disease progression in people with multiple sclerosis. The research, conducted over six months, found that those who engaged in resistance training had less brain shrinkage and even small brain areas began to grow.
Women who breastfed for 15 months or more have a reduced risk of developing multiple sclerosis (MS) compared to those with no breastfeeding. The study, published in Neurology, found that this association held true even when considering factors like age and ovulation.
A recent study suggests that the human herpesvirus 6 (HHV-6) may impede the brain's ability to repair itself in diseases like multiple sclerosis. The virus produces a protein called U94 that can impair the normal function of cells in the brain, potentially accelerating disease progression.
A study found that MS patients with higher scores on a standardised questionnaire were more likely to die in the next 10 years. The Multiple Sclerosis Impact Scale (MSIS-29) asks patients to rate their symptoms, which can help doctors predict clinical outcomes and tailor treatment.
A randomized double-blind study involving 51 participants found a 68% improvement in slowing whole brain atrophy in patients with secondary progressive MS. Lipoic acid also improved walking times and reduced falls compared to placebo.
Shared decision-making between patients and healthcare providers is essential for optimal MS treatment and quality of life. The process involves working together to select tests, treatments, and care plans, taking into account evidence-based treatments and lifestyle factors.
Researchers at UMD's Jewell Laboratory have developed a precision system using quantum dots to control the display of self-antigens, promoting tolerance and elimination of paralysis in pre-clinical mouse models. This breakthrough could pave the way for more selective and effective therapies for MS and other autoimmune diseases.
Alemtuzumab's phase III trial datasets reveal a massive re-population of B cells in MS patients, leading to secondary autoimmune disease. The study suggests controlling this 'overshoot' may limit risk and make the drug more effective.
A study found that people with multiple sclerosis (MS) have impaired ability to understand others' feelings and intentions, linked to subtle brain changes, particularly in the white matter of the brain. The results suggest a disconnect in the social brain network, affecting quality of life and daily interactions.
A Canadian clinical trial has discovered that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis in people experiencing their first symptoms. The treatment offers a safe and affordable alternative to current therapies, which can cost up to $40,000 per year.
A new treatment modality called PPCA has been discovered that targets the DNA damage in rapidly expanding T cells, reducing autoimmune damage in mouse models of hemophagocytic lymphohistiocytosis (HLH) and multiple sclerosis (MS). The therapy, which leverages p53 potentiation with checkpoint abrogation, selectively interrupts DNA damag...
A novel study has identified new biomarkers of multiple sclerosis pathogenesis, revealing a central role for interferon gamma in brain inflammation. The research found that high serum interferon gamma levels activate astrocytes, triggering an inflammatory response and promoting the migration of autoreactive T lymphocytes into the brain.
John DeLuca, Ph.D., of Kessler Foundation has been awarded the Mentor-Based Postdoctoral Fellowship Award in Neuropsychological Rehabilitation from the National Multiple Sclerosis Society. The five-year grant will support Kessler Foundation's postdoctoral fellowship training program and fund research on cognitive deficits in MS.
A comprehensive study by UBC researchers found an increased risk of stroke, migraine, depression, and abnormalities in the blood with beta interferon treatment. The study complements previous observations and highlights the need for further research on developing biomarkers to identify patients at greatest risk.
Researchers at Case Western Reserve University have developed a neural stimulation system that improves walking ability for stroke and MS patients. Functional electrical stimulation (FES) significantly helped patients walk more effectively, with one patient covering nearly a mile and another gaining balance and confidence.
A study by Queen Mary University of London found that axonal loss in multiple sclerosis (MS) is not the sole cause of chronic disability. The researchers discovered a substantial loss of synaptic connections in the MS spinal cord, which may drive disability. This new understanding could help identify targets for new treatments.
Researchers at National Jewish Health have identified Age-associated B Cells (ABCs) as a key driver of autoimmune diseases such as lupus and Crohn's disease. The study found that ABCs cause the immune system to attack organs and tissues, leading to chronic inflammation and tissue damage.
New research published in the Journal of Leukocyte Biology found that smoking decreases frequencies of MAIT cells in healthy individuals and patients with multiple sclerosis. This discovery sheds light on the effects of smoking on the immune system, potentially revealing pathogenic mechanisms contributing to autoimmune diseases.
Researchers have discovered a new cellular mechanism - an underlying defect in brain cells - that may cause multiple sclerosis. A protein called Rab32 is present in large quantities in the brains of people with MS but virtually absent in healthy brain cells.
A preliminary study suggests that removing Epstein-Barr virus-infected B cells and boosting the immune system may improve symptoms of multiple sclerosis. Three participants showed significant improvements, including one person with secondary progressive MS who was able to walk without assistance for the first time in 20 years.
A new study reveals that people with multiple sclerosis can show signs of the disease five years before its official diagnosis. Researchers analyzed health records from 14,000 patients with MS and found that they were more likely to visit their physicians and fill prescriptions earlier than others.
Scientists have identified two genetic mutations that significantly increase the risk of developing multiple sclerosis. The double gene mutation was found in a large Canadian family with five members diagnosed with MS, revealing new insights into the disease's origins and potential targets for treatment.
Researchers developed an experimental treatment that tames the immune system in rodents, restoring movement to paralyzed mice. The approach may combat autoimmune diseases in humans, as demonstrated in mouse models of multiple sclerosis and type 1 diabetes.
Researchers have restored nerve insulation and improved limb mobility in mice with multiple sclerosis by treating them with a microRNA called miR-219. The treatment reinvigorated the function of damaged cells that produce myelin, allowing it to reform and reinsulate nerves.
Researchers at U of A have identified a potential target for treating multiple sclerosis by discovering an underlying defect in brain cells. The study found that two sub-components within a cell are miscommunicating in patients with MS, triggering dysfunction and toxicity for brain cells.
Scientists at UTMB and Duke University Medical Center found a new gene interaction that increases the risk of developing multiple sclerosis. This discovery could lead to more accurate tests to identify those at greatest risk and potentially uncover new avenues for treatment.
A new home-based telemedicine program will be developed and pilot-tested to treat multiple sclerosis patients. The program, funded by a $100,000 Genentech grant, aims to improve care for people with advanced MS living in medically underserved communities.
Researchers at UMass Amherst are creating an improved diagnostic test to help track symptoms and diagnose patients with progressive multiple sclerosis. The two-year project aims to detect subtle changes in sensory and motor function, enabling early treatments to slow disability progression.
A controlled study by UBC-Vancouver Coastal Health research shows no added benefit from opening narrowed veins in treating multiple sclerosis. The findings debunk the claim that patients could achieve dramatic improvements from liberation therapy, an invasive procedure with significant financial cost and risk of complications.
Researchers have used modified red blood cells to deliver disease-specific antigens, preventing and alleviating multiple sclerosis and type 1 diabetes in early stage mouse models. The approach shows promise for inducing tolerance and could lead to new therapies for autoimmune diseases.
A preliminary study found that individuals with relapsing-remitting MS who experience fatigue and limited leg function are at higher risk of progressing to secondary progressive MS. The study suggests that tailored treatments may be more effective for these patients, providing valuable insights into predicting MS progression.
A large-scale study found a significant association between autoimmune diseases and increased risk of dementia, particularly Alzheimer's. People admitted to hospital for autoimmune diseases were 20% more likely to be readmitted for dementia compared to those with other conditions.
A new study published in Neuromodulation found that transcranial direct current stimulation (tDCS) combined with computer games significantly improved cognitive measures in patients with multiple sclerosis. The treatment showed greater gains in complex attention and response times compared to those who played computer games alone.
A UC Riverside study found that chronic demyelination is closely linked to seizures in MS patients, with specific neurons being lost and hyperactivity increasing. The researchers hope to develop drugs aimed at reducing seizures, which could also benefit epilepsy patients.
A type of autologous hematopoietic stem cell transplantation (AHSCT) has been shown to slow or stop MS disease progression for up to five years in nearly half of patients, with significant benefits seen in younger patients and those with relapsing-remitting MS. However, the treatment carries a small risk of death and is not suitable fo...
A study of 281 patients with aggressive MS who underwent autologous hematopoietic stem cell transplantation found a 46% five-year progression-free survival rate. Younger age, relapsing form of MS, and fewer prior immunotherapies were associated with better outcomes.
A research team at Brigham and Women's Hospital has revealed how FTY720 suppresses chronic inflammation in the central nervous system to reduce pathogenic activities of astrocytes. The findings suggest this treatment may hold promise for progressive and difficult-to-treat forms of multiple sclerosis.
A new therapeutic agent, ST266, has been shown to prevent loss of cells in the optic nerve and reduce inflammation in a mouse model of multiple sclerosis. Early treatment with ST266 improved visual function and prevented damage to the optic nerve.
High-dose immunosuppressive therapy followed by stem cell transplantation has been shown to induce sustained remission in relapsing-remitting multiple sclerosis. Five years after treatment, 69% of participants had survived without progression or relapse, with some showing improvements in mobility and physical capabilities.
A new study found that serum microRNAs are associated with MRI measures of multiple sclerosis severity, suggesting they could serve as biomarkers. The research identified distinct microRNA sets linked to lesions and atrophy, which may help identify underlying disease processes and guide therapeutic decisions.
A team led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold report two patients who developed severe symptoms under alemtuzumab, a common MS treatment. The researchers successfully treated the side effects with a new algorithm that could benefit other patients worldwide.